# A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males

> **NCT02149264** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 160 (actual)

## Conditions studied

- Adult Male Hypogonadism

## Interventions

- **DRUG:** Testosterone gel (FE 999303)

## Key facts

- **NCT ID:** NCT02149264
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149264, "A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02149264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*